| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/20/2008 | CN100369914C 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 02/20/2008 | CN100369908C New taxane derivatives |
| 02/20/2008 | CN100369899C Substituted indazoles with anti-cancer activity |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/20/2008 | CN100369632C Anti-cancer medicine composition |
| 02/20/2008 | CN100369606C Inclusion containing raltitrexed and preparation |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | US7332590 Using serial analysis of gene expression to identify tumor marker gene transcription products in respiratory system tissues; diagnosing/prognosing lung cancer |
| 02/19/2008 | US7332572 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 02/19/2008 | US7332523 TNP-470 polymer conjugates and use thereof |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332488 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332478 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/19/2008 | US7332335 Increasing expression of p21WAF1/Cip 1 in cells to decrease proliferation of the cells by decreasing levels of PP5 protein in the cells. |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332293 Neutral amino acid transporter binding method |
| 02/19/2008 | US7332287 Methods and compositions for diagnosing breast cancer |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332174 Mutant forms of cholera holotoxin as an adjuvant |
| 02/19/2008 | US7332149 Diagnosis, therapy of cancer, rheumatoid arthritis, for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature, imaging tumors, atherosclerosis, restenosis, cardiac ischemia, and myocardial reperfusion injury |
| 02/19/2008 | CA2436572C Perylenequinones for use as photosensitizers and sonosensitizers |
| 02/19/2008 | CA2326761C Antitumor agent |
| 02/19/2008 | CA2273240C Compositions and methods for treating or preventing inflammatory diseases |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/19/2008 | CA2197210C Intravenous alendronate formulations |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/19/2008 | CA1341567C Dna sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides |
| 02/14/2008 | WO2008019378A1 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 02/14/2008 | WO2008019326A2 Ephb3-specific antibody and uses thereof |
| 02/14/2008 | WO2008019290A2 Human antibodies to erbb 2 |
| 02/14/2008 | WO2008019135A1 Antiproliferative activity of the leiodermatolide class of macrolides |
| 02/14/2008 | WO2008019124A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 02/14/2008 | WO2008019065A1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 02/14/2008 | WO2008018881A1 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors |
| 02/14/2008 | WO2008018783A2 Porphyrin activation by different spectrum electromagnetical waves-new malignant tumour treatment possibilities |
| 02/14/2008 | WO2008018778A1 New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer |
| 02/14/2008 | WO2008018655A1 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018517A1 Therapeutic and/or preventive agent for disease accompanied by cell overgrowth, and polynucleotide useful as the active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018426A1 Pyrimidine derivative as pi3k inhibitor and use thereof |
| 02/14/2008 | WO2008018140A1 Composition for preventing and/or treating tumor containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008017883A2 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 02/14/2008 | WO2008017855A1 Osmium compounds |
| 02/14/2008 | WO2008017845A1 Apples with high polyphenolic content |
| 02/14/2008 | WO2008017842A1 Polyphenol extraction process |
| 02/14/2008 | WO2008017594A1 Thieno[3,2-c]pyridine-7-carboxylic acid derivatives |
| 02/14/2008 | WO2008017568A1 Plasmids with immunological action |
| 02/14/2008 | WO2008017515A1 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 02/14/2008 | WO2008017473A2 Structure and use of 5' phosphate oligonucleotides |
| 02/14/2008 | WO2008017465A1 Bicyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 02/14/2008 | WO2008017206A1 A percutaneous intratumoral injection composition for treating thyroma |
| 02/14/2008 | WO2008008493A3 Alkyne-substituted pyridone compounds and methods of use |
| 02/14/2008 | WO2008005954A3 Tryphostin-analogs for the treatment of cell proliferative diseases |
| 02/14/2008 | WO2008002571A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | WO2008002570A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | WO2008002569A3 Human protein tyrosine phosphatase inhibitors and methods of use |
| 02/14/2008 | WO2007149891A3 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 02/14/2008 | WO2007148341A3 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity |
| 02/14/2008 | WO2007144554A3 Gnrh (gonadotropin-releasing hormone) peptide variants |
| 02/14/2008 | WO2007143600A3 Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases |
| 02/14/2008 | WO2007084344A3 Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 02/14/2008 | WO2007080194A3 Use of tpp ii inhibitors in combination with gamma-irradiation for the treatment of cancer |
| 02/14/2008 | WO2007031875A3 Modified antigen binding molecules with altered cell signaling activity |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039521 Anticancer Effect Enhancer |
| 02/14/2008 | US20080039518 Maleiimide anti-tumor phosphatase inhibitors |
| 02/14/2008 | US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity |
| 02/14/2008 | US20080039508 Treatment Of Tumours |
| 02/14/2008 | US20080039491 Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use |
| 02/14/2008 | US20080039489 Tetrahydrofuran derivatives for use as inhibitors of matrix metalloproteinases |
| 02/14/2008 | US20080039486 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 02/14/2008 | US20080039483 Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents |
| 02/14/2008 | US20080039482 Sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039477 Pyrazolopyrimidines as Cell Cycle Kinase Inhibitors |
| 02/14/2008 | US20080039473 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039468 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof |
| 02/14/2008 | US20080039466 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors |
| 02/14/2008 | US20080039460 2-Chloro-N-(2-thiophen-2-yl-3H-imidazo[4,5-b]pyridin-6-yl)-benzamide; cancer |
| 02/14/2008 | US20080039459 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/14/2008 | US20080039457 Triazolotriazines as kinase inhibitors |
| 02/14/2008 | US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 02/14/2008 | US20080039455 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |